reviewrheumatoid arthritispathogenesisimmunodiagnosisimmunogeneticscellular mechanismsобзорревматоидный артритпатогенезиммунодиагностикаиммуногенетикаклеточные механизмы1.Davidson A., Diamond В. Autoimmune diseases. N. Engl. J. Med. 2001; 345 (5): 340-350.2.Cunnane G., Doran M., Bresnihan B. Infections and biological therapy in rheumatoid arthritis. Best Pract. Res. Clin. Rheumatol. 2003; 17 (2): 345-363.3.Taylor P. С Anti-cytokines and cytokines in the treatment of rheumatoid arthritis. Curr. Pharm. Des. 2003; 9 (14): 1095- 1106.4.Firestein G. S. Evolving concepts of rheumatoid arthritis. Nature 2003; 423 (6937): 356-361.5.Nepom G. T. et al. HLA genes associated with rheumatoid arthritis: identification of susceptibility alleles using specific oligonucleotide probes. Arthr. and Rheum. 1989; 32: 15-21.6.Gonzakz-Juanatey C., Testa A., Garcia-Castelo A. et al. Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Semin. Arthr. Rheum. 2004; 33 (4): 231 - 238.7.Benoist C., Mathis D. Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nature Immunol. 2001; 2(9): 797-801.8.Balandraud N., Meynard J. В., Auger I. et al. Epstein-Barr virus load in the peripheral blood of patients with rheumatoid arthritis: accurate quantification using real-time polymerase chain reaction. Arthr. and Rheum. 2003; 48 (5): 1223-12289.Salmon M., Gaston J. S. The role of T-lymphocytes in rheumatoid arthritis. Br. Med. Bull. 1995; 51: 332-345.10.Torres B. A., Johnson H. M. Modulation of disease by superantigens. Curr. Opin. Immunol. 1998; 10: 465-470.11.Shaw A. S., Dustin M. L. Making the T cell receptor go the distance: a topological view of T cell activation. Immunity 1997; 6: 361-369.12.Morita Y., Yamamura M., Kawashima M. et al. Flow cytometric single-cell analysis of cytokine prodviction by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthr. and Rheum. 1998; 41: 1669-1676.13.Van der Heijden I. M. et al. Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthr. and Rheum. 2000; 43: 593-598.14.Kang Y. M., Zhang X., Wagner U. G. et al. CD8+ T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J. Exp. Med. 2002; 195: 1325-1336.15.Christopherson K. W., Hromas R. A. Endothelial chemokines in autoimmune disease. Curr. Pharm. Des. 2004; 10 (2): 145- 154.16.Tussey L., Speller S., Gallimore A., Vessey R. Functionally distinct CD8+ memory T cell subsets in persistent EBV infection are differentiated by migratory receptor expression. Eur. J. Immunol. 2000; 30: 1823-1829.17.Sallusto F., Lenig D., Forster R. et al. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708-712.18.Maldonado A., Mueller Y. M., Thomas P. et al. Decreased effector memory CD45RA+CD62L- CD8+ T cells and increased central memory CD45RA-CD62L+ CD8+ T cells in peripheral blood of rheumatoid arthritis patients. Arthr. Res. Ther. 2003; 5 (2): 91-96.19.Naor D., Nedvetzki S. Cd44+ in rheumatoid arthritis. Arthr. Res. Ther. 2003; 5 (3): 105-115.20.Grom A. A. Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthr. and Rheum. 2004; 50 (3): 689-698.21.Hammond K. J., Godfrey D. I. NKT cells: potential targets for autoimmune disease therapy? Tissue Antigens 2002; 59 (5): 353-363.22.Сперанский А. И., Иванова С. М. Аутоиммунные болезни (клинические и теоретические аспекты). Аллергол. и иммунол. 2002; 3 (1): 62-83.23.D'Cruz D. Testing for autoimmunity in humans. Toxicol. Lett. 2002; 127 (1-3): 93-100.24.Zhou Z., Menard H. A. Autoantigenic posttranslational modifications of ptoteins: does it apply to rheumatoid arthritis? Curr. Opin. Rheumatol. 2002; 14 (3): 250-253.25.Сучков С. В. Механизмы цитотоксичности анти-ДНК-аутоантител. Бюл. экспер. биол. 2001; 131 (5): 560-563.26.Сучков С. В., Габибов А. Г., Гнучев Н. В. ДНК-абзимы и их каталитические свойства. Журн. биол. мед. и фармац. химии. 2001; 3: 114-119.27.Ohmori H., Капауата N. Mechanisms leading to autoantibody production: link between inflammation and autoimmunity. Curr. Drug Targets Inflamm. Allerg. 2003; 2 (3): 232-241.28.Smeets T. J. et al. Poor expression of T cell-derived cytokines and activation and proliferation markers in early rheumatoid synovial tissue. Clin. Immunol. Immunopathol. 1998; 88: 84- 90.29.Dayer J. M. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis. Rheumatology 2003; 42 (suppl. 2): 3-10.30.Bough J. A., Bucala R. Mechanisms for modulating TNF alpha in immune and inflammatory disease. Curr. Opin. Drug Discov. Dev. 2001; 4 (5): 635-650.31.Brennan F. M., Chantry D., Jackson A., et al. Inhibitory effect of TNF-a antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 2001; 2: 244-247.32.Schuerwegh A. J., Dombrecht E. J., Stevens W. J. et al. Influence of proinflammatory (IL-1-alpha, IL-6, TNF-alpha, IFN- gamma) and anti-inflammatory (IL-4) cytokines on chondrocyte function. Osteoarthr. Cartilage 2003; 11 (9): 681-687.33.Lubberts E. The role of IL-17 and family members in the pathogenesis of arthritis. Curr. Opin. Invest. Drugs 2003; 4 (5): 572-577.34.Grade J. A. et al. A proinflammatory role for IL-18 in rheumatoid arthritis. J. Clin. Invest. 1999; 104: 1393-1401.35.Andersson U., Erlandsson-Harris H. HMGBl is a potent trigger of arthritis. J. Intern. Med. 2004; 255 (3): 344-350.36.Leech M., Lacey D., Xue J. R. et al. Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis. Arthr. and Rheum. 2003; 48 (7): 1881-1889.37.Schett G. et al. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signalregulated kinase, c-JUN N-terminal kinase, and p38 mitogenactivated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthr. and Rheum. 2000; 43: 2501-2512.38.Shiozawa S., Shimizu K., Tanaka K., Hino K. Studies on the contribution of c-fos/AP-1 to arthritic joint destruction. J. Clin. Invest. 1997; 99: 1210-1216.39.Schultz D. R., Harrington W. J. Apoptosis: programmed cell death at a molecular level. Semin. Arthr. Rheum. 2003; 32 (6): 345-369.40.Perlman H., Pagliari L. J., Volin M. V. Regulation of apoptosis and cell cycle activity in rheumatoid arthritis. Curr. Mol. Med. 2001; 1 (5): 597-608.41.Baier A., Meineckel I., Gay S., Pap T. Apoptosis in rheumatoid arthritis. Curr. Opin. Rheumatol. 2003; 15 (3): 274-279.42.Liu H. et al. TNF-a gene expression in macrophages: regulation by NF-кВ is independent of c-Jun or C/EBPp. J. Immunol. 2000; 164: 4277-4285.43.Liu H., Perlman H., Pagliari L., Pope R. Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages: role of Mcl-1, independent of NF-кВ, Bad or caspase activation. J. Exp. Med. 2001; 194: 113-125.44.Kirwan J. R. The synovium in rheumatoid arthritis: evidence for (at least) two pathologies. Arthr. and Rheum. 2004; 50 (1): 1-4.45.Lubberts E. et al. IL-17 promotes bone erosion in murine collagen-induced arthlitis through loss of the receptor activator of NF-кВ ligand/osteoprotegerin balance. J. Immunol. 2003; 170: 2655-2662.46.Gotdring S. R., Gravallese E. M. Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications. Arthr. Res. Ther. 2000; 2: 33-37.47.Goronzy J. J., Weyand С. М., Ageing, autoimmunity and arthritis T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation. Arthr. Res. Ther. 2003; 5: 225-234.48.Sibbitt W. L. Oncogenes, growth factors, and autoimmune diseases (review). Anticancer Res. 1991; 11 (1): 97-113.49.Imamura F. et al. Monoclonal expansion of synoviocytes in rheumatoid arthritis. Arthr. and Rheum. 1998; 41: 1979-1986.50.Walsh D. A., Wade M., Mapp P. I., Blake D. R. Focally regulated endothelial proliferation and cell death in human synovium. Am. J. Pathol. 1998; 152: 691-702.51.Inazuka M. et al. Analysis of p53 tumour suppressor gene somatic mutations in rheumatoid arthritis synovium. Rheumatology 2000; 39: 262-266.52.Fnoue K., Kumagai C., Nishioka T. et al. Malignant rheumatoid arthritis in the young with polyneuritis as an initial symptom. Nippon Naika Gakkai Zasshi 2004; 83 (1): 134-136.